Met Life Investment Management, LLC Mersana Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 33,916 shares of MRSN stock, worth $54,265. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,916
Previous 65,583 48.29%
Holding current value
$54,265
Previous $131,000 51.15%
% of portfolio
0.0%
Previous 0.0%

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$1.23 - $2.25 $38,950 - $71,250
-31,667 Reduced 48.29%
33,916 $64,000
Q2 2024

Aug 13, 2024
BUY
$2.0 - $4.45 $31,368 - $69,793
15,684 Added 31.43%
65,583 $131,000
Q1 2024

May 14, 2024
BUY
$2.16 - $5.94 $107,781 - $296,400
49,899 New
49,899 $223,000
Q2 2023

Apr 29, 2024
BUY
$3.08 - $9.55 $143,657 - $445,431
46,642 New
46,642 $153,000
Q1 2023

May 09, 2024
BUY
$4.0 - $7.02 $186,568 - $327,426
46,642 New
46,642 $192 Million
Q3 2022

May 10, 2024
BUY
$4.63 - $8.0 $37,720 - $65,176
8,147 Added 21.16%
46,642 $315,000
Q3 2022

Mar 22, 2023
BUY
$4.63 - $8.0 $37,720 - $65,176
8,147 Added 21.16%
46,642 $315,000
Q3 2022

Nov 14, 2022
BUY
$4.63 - $8.0 $37,720 - $65,176
8,147 Added 21.16%
46,642 $315,000
Q2 2022

May 10, 2024
BUY
$2.84 - $5.0 $38,402 - $67,610
13,522 Added 54.15%
38,495 $177,000
Q2 2022

Jun 20, 2023
SELL
$2.84 - $5.0 $23,137 - $40,735
-8,147 Reduced 17.47%
38,495 $177,000
Q2 2022

Mar 22, 2023
BUY
$2.84 - $5.0 $38,402 - $67,610
13,522 Added 54.15%
38,495 $177,000
Q2 2022

Aug 11, 2022
BUY
$2.84 - $5.0 $38,402 - $67,610
13,522 Added 54.15%
38,495 $178,000
Q1 2022

May 10, 2024
BUY
$3.74 - $6.63 $93,399 - $165,570
24,973 New
24,973 $99,000
Q1 2022

Jun 20, 2023
SELL
$3.74 - $6.63 $81,042 - $143,665
-21,669 Reduced 46.46%
24,973 $99,000
Q1 2022

Mar 22, 2023
SELL
$3.74 - $6.63 $7,667 - $13,591
-2,050 Reduced 7.59%
24,973 $99,000
Q1 2022

May 12, 2022
SELL
$3.74 - $6.63 $7,667 - $13,591
-2,050 Reduced 7.59%
24,973 $100,000
Q4 2021

May 17, 2024
BUY
$5.48 - $9.86 $52,909 - $95,198
9,655 Added 55.59%
27,023 $168,000
Q4 2021

Jun 21, 2023
SELL
$5.48 - $9.86 $107,512 - $193,443
-19,619 Reduced 42.06%
27,023 $168,000
Q4 2021

Mar 22, 2023
BUY
$5.48 - $9.86 $52,909 - $95,198
9,655 Added 55.59%
27,023 $168,000
Q4 2021

Feb 15, 2022
BUY
$5.48 - $9.86 $52,909 - $95,198
9,655 Added 55.59%
27,023 $168,000
Q3 2021

May 17, 2024
SELL
$8.56 - $14.47 $72,391 - $122,372
-8,457 Reduced 32.75%
17,368 $163,000
Q3 2021

Jun 21, 2023
SELL
$8.56 - $14.47 $250,585 - $423,594
-29,274 Reduced 62.76%
17,368 $163,000
Q3 2021

Mar 22, 2023
SELL
$8.56 - $14.47 $72,391 - $122,372
-8,457 Reduced 32.75%
17,368 $163,000
Q3 2021

Nov 15, 2021
SELL
$8.56 - $14.47 $72,391 - $122,372
-8,457 Reduced 32.75%
17,368 $164,000
Q2 2021

May 17, 2024
BUY
$13.28 - $18.07 $62,097 - $84,495
4,676 Added 22.11%
25,825 $350,000
Q2 2021

Jun 21, 2023
SELL
$13.28 - $18.07 $276,449 - $376,163
-20,817 Reduced 44.63%
25,825 $350,000
Q2 2021

Mar 22, 2023
BUY
$13.28 - $18.07 $62,097 - $84,495
4,676 Added 22.11%
25,825 $350,000
Q2 2021

Aug 16, 2021
BUY
$13.28 - $18.07 $62,097 - $84,495
4,676 Added 22.11%
25,825 $351,000
Q1 2021

May 17, 2024
SELL
$15.31 - $26.52 $440,162 - $762,450
-28,750 Reduced 57.62%
21,149 $342,000
Q1 2021

Jun 26, 2023
SELL
$15.31 - $26.52 $390,297 - $676,074
-25,493 Reduced 54.66%
21,149 $342 Million
Q1 2021

Mar 22, 2023
SELL
$15.31 - $26.52 $27,052 - $46,860
-1,767 Reduced 7.71%
21,149 $342,000
Q1 2021

May 14, 2021
SELL
$15.31 - $26.52 $27,052 - $46,860
-1,767 Reduced 7.71%
21,149 $342,000
Q4 2020

Jun 22, 2023
SELL
$16.84 - $27.59 $399,545 - $654,600
-23,726 Reduced 50.87%
22,916 $609,000
Q3 2020

May 24, 2024
BUY
$16.2 - $25.7 $34,619 - $54,920
2,137 Added 10.28%
22,916 $427 Million
Q3 2020

Jun 26, 2023
SELL
$16.2 - $25.7 $384,361 - $609,758
-23,726 Reduced 50.87%
22,916 $426,000
Q3 2020

Mar 22, 2023
BUY
$16.2 - $25.7 $34,619 - $54,920
2,137 Added 10.28%
22,916 $426,000
Q3 2020

Nov 13, 2020
BUY
$16.2 - $25.7 $34,619 - $54,920
2,137 Added 10.28%
22,916 $427,000
Q2 2020

May 24, 2024
SELL
$5.24 - $23.4 $152,588 - $681,408
-29,120 Reduced 58.36%
20,779 $486 Million
Q2 2020

Jun 26, 2023
SELL
$5.24 - $23.4 $135,522 - $605,194
-25,863 Reduced 55.45%
20,779 $486,000
Q2 2020

Mar 22, 2023
BUY
$5.24 - $23.4 $12,754 - $56,955
2,434 Added 13.27%
20,779 $486,000
Q2 2020

Aug 14, 2020
BUY
$5.24 - $23.4 $12,754 - $56,955
2,434 Added 13.27%
20,779 $486,000
Q1 2020

Jul 12, 2023
SELL
$4.41 - $9.28 $124,789 - $262,596
-28,297 Reduced 60.67%
18,345 $106,000
Q1 2020

Mar 22, 2023
SELL
$4.41 - $9.28 $124,789 - $262,596
-28,297 Reduced 60.67%
18,345 $106,000
Q1 2020

May 15, 2020
BUY
$4.41 - $9.28 $80,901 - $170,241
18,345 New
18,345 $107,000

Others Institutions Holding MRSN

# of Institutions
121
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $155M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email